Senegal donates 20,000 Chinese vaccines to The Gambia, Guinea-Bissau

Senegal is the first African country to donate vaccines to its neighbours as Dakar announced today that it will give 10,000 doses each of its Chinese coronavirus vaccines to The Gambia and Guinea-Bissau.

Health Minister Abdoulaye Diouf Sarr – the first to receive a jab today (February 23, 2021) announced that the donation was a sign of solidarity. President Macky Sall confirmed the donation.

Read More: EFCC Chair: How Malami misled President Buhari

Senegal received a vaccine consignment of 200,000 from China’s Sinopharm. Government said it paid a little over 2 billion CFA francs ($3.74 million) for the doses to kickstart its campaign.

Senegal says it is also in negotiations with Russia to purchase its Sputnik V vaccine.

“We are in the process of finalizing our commercial relationship with Russia to bring in the Sputnik V vaccine very soon,” he said, adding that Senegal also aimed to get more vaccines from an African Union vaccines programme.

So far only five African countries have okayed the use of Sputnik V, they are Algeria, Tunisia, Gabon, the Republic of Guinea and more recently, Ghana.
Senegal donates 20,000 Chinese vaccines to The Gambia, Guinea-Bissau
Senegal donates 20,000 Chinese vaccines to The Gambia, Guinea-Bissau

Senegal aims to inoculate about 90% of a targeted 3.5 million people, including health workers and high-risk individuals between the ages of 19 and 60, by the end of 2021. The country’s population is about 16 million.

As a lower-middle income country, Senegal is eligible for about 1.3 million vaccine doses for free through the first wave of the World Health Organization’s COVAX programme. Sarr said they were expected to arrive in early March.

The country is also eligible to get 3.4 million doses for just under $23 million under an African Union plan.

With additional files from Reuters

Source: Mynewsghana.net

Get real time updates directly on you device, subscribe now.

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More